Out-of-pocket costs continue to increase for patients who must buy commonly prescribed drugs to treat these five neurological ...

A team of international researchers including those from the University of Adelaide have taken a well-known chemical reaction ...

The amount of money people pay out-of-pocket for branded drugs to treat neurological diseases like multiple sclerosis (MS), Alzheimer's, and Parkinson's disease continues to rise, especially for MS ...

Vitamins and mineral supplements can help address nutritional deficiencies that commonly affect people who have Crohn’s ...

The Bcl-2 inhibitor venetoclax is highly effective and is another first- or second-line option even if this agent, like BTK inhibitors, also appears to require continuous dosing, said Stadtmauer, ...

Living with a chronic pain condition can make everyday tasks more challenging. For some people in Southern Utah dealing with ...

Harvard Medical School has said out that a tingling sensation in the feet could be a sign of a vitamin B12 deficiency. It ...

A person battling multiple sclerosis spent an average of $750 in out-of-pocket fees on medicines in 2012, but by 202 ...

In addition, these factors also stimulate inflammation-related damage to the nervous system, contributing to ...

New data will showcase significantly increased and sustained minimal residual disease (MRD) negativity rates, reinforcing the potential of ...

In this case report, Gad and colleagues performed corneal confocal microscopy to assess for evidence of nerve regeneration ...

Suneeta’s research centers on identifying novel molecular signatures and biomarkers to improve the efficacy of cancer ...